▎药明康德内容团队编辑参考资料: [1] FDA. Rare Disease Cures Accelerator. May 29, 2020. Retrieved May 30, 2020 from https://www./drugs/regulatory-science-research-and-education/rare-disease-cures-accelerator [2] FDA. Rare Disease Clinical Trial Networks; Request for Information and Comments. Jun 1, 2020. Retrieved Jun 1, 2020 from https://www./content/pkg/FR-2020-06-01/pdf/2020-11655.pdf [3] FDA. FDA In Brief: FDA Requests Input on Rare Disease Clinical Trial Networks. May 29. 2020. Retrieved May 30, 2020 from https://www./news-events/fda-brief/fda-brief-fda-requests-input-rare-disease-clinical-trial-networks?utm_campaign=SBIA%3A%20Rare%20Disease%20Network&utm_medium=email&utm_source=Eloqua [4] Kari Oakes. FDA seeks input on rare disease clinical trials network. May 29, 2020. Retrieved May 30, 2020 from https://www./news-and-articles/news-articles/2020/5/fda-seeks-input-on-rare-disease-clinical-trials-ne [5] C-Path (Critical Path Institute). Rare Disease Cures Accelerator-Data and Analytics Platform. Retrieved May 30, 2020 from https:///programs/rdca-dap/ [6] RDCRN. Rare Diseases Research Groups & Studies. Retrieved May 29, 2020 from https://www./research-groups [7] NORD. What you want and need to know about the Rare Disease Cures Accelerator – Data and Analytics Platform, May 27, 2020 Retrieved May 29, 2020 from https:///wp-content/uploads/2020/05/RDCA-DAP_Patient_Organization_Webinar_May_2020.pdf |
|